PET Scan as a Screening Tool for Liver Transplant in Patients With HCC
N/A
18 Years
75 Years
18 Years
75 Years
Open (Enrolling)
Both
Hepatocellular Carcinoma
Both
Hepatocellular Carcinoma
Trial Information
PET Scan as a Screening Tool for Liver Transplant in Patients With HCC
Inclusion Criteria:
- Male or female patient over 18 years of age
- Diagnosis of HCC confirmed by histology if available or by two imaging modalities
- Able to give written informed consent prior to any study specific screening
procedures with the understanding that the patient has the right to withdraw from the
study at any time, without prejudice.
Exclusion Criteria:
- Unable to give consent to the study
- Unable to undergo a PET Scan
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
Outcome Measure:
Overall Survival
Outcome Description:
The primary objective of the study is to compare, according to PET scan results, the post-transplantation overall survival of patients meeting Milan criteria to those not meeting Milan criteria
Outcome Time Frame:
up to death
Safety Issue:
No
Authority:
Canada: Health Canada
Study ID:
BMD-09-209
NCT ID:
NCT01320852
Start Date:
December 2010
Completion Date:
December 2013
Related Keywords:
- Hepatocellular Carcinoma
- Transplant
- Carcinoma
- Carcinoma, Hepatocellular
Name | Location |
|---|
